Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial.

Nianhua DingJian PangXuan LiuXiongbin HeWei ZhouHaiqing XieJianqi FengGuo WangJie TangJing CaoLiying HeYingjian HeShouman WangZhi Xiao

Published in: Breast cancer research : BCR (2024)

A low baseline NLR is associated with better survival outcomes among HER2-positive MBC patients receiving docetaxel plus trastuzumab/pertuzumab as first-line therapy.

Keyphrases

metastatic breast cancer
study protocol
electronic health record
phase iii
big data
squamous cell carcinoma
stem cells
locally advanced
free survival